These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 5125661
21. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization. Rutanen EM, Lindgren J, Sipponen P, Stenman UP, Saksela E, Seppäla M. Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771 [No Abstract] [Full Text] [Related]
23. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Hellström I, Sjögren HO, Warner G, Hellström KE. Int J Cancer; 1971 Mar 15; 7(2):226-37. PubMed ID: 5104167 [No Abstract] [Full Text] [Related]
24. Use of immune lymphocytes to detect expression of herpetic genome. Sprecher-Goldberger S, Thiry L, Vandenbussche P. Nature; 1974 Aug 23; 250(5468):678-9. PubMed ID: 4369425 [No Abstract] [Full Text] [Related]
25. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma. Cummings KB, Peter JB, Kaufman JJ. J Urol; 1973 Jul 23; 110(1):31-5. PubMed ID: 4713354 [No Abstract] [Full Text] [Related]
26. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas. Cohen AM, Ketcham AS, Morton DL. Surgery; 1972 Oct 23; 72(4):560-7. PubMed ID: 4506654 [No Abstract] [Full Text] [Related]
27. A review of tumor antigens in gynecologic malignancies. Gall SA. J Reprod Med; 1975 Jan 23; 14(1):12-6. PubMed ID: 162963 [Abstract] [Full Text] [Related]
28. [Antigenic specificity of the polysaccharide fraction of ovarian adenocarcinoma in the delayed hypersensitivity reaction]. Ul'chenko VM, Gorodilova VV, Bashkaev IS. Vopr Onkol; 1976 Jan 23; 22(3):3-7. PubMed ID: 936525 [No Abstract] [Full Text] [Related]
29. An immunohistochemical study of colon-ovarian tumor antigen and colon-specific antigen in gynecologic tumors. Ueda G, Shimizu C, Saito J, Tanaka Y, Inoue M, Tanizawa O. Gynecol Oncol; 1989 Oct 23; 35(1):90-2. PubMed ID: 2792910 [Abstract] [Full Text] [Related]
30. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique. Jagarlamoody SM, Aust JC, Tew RH, McKhann CF. Proc Natl Acad Sci U S A; 1971 Jun 23; 68(6):1346-50. PubMed ID: 4331089 [Abstract] [Full Text] [Related]
31. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy. Veltman LL, Kern DH, Pilch YH. Am J Obstet Gynecol; 1974 Aug 01; 119(7):959-65. PubMed ID: 4135321 [No Abstract] [Full Text] [Related]
32. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. Bloom ET. Cancer Res; 1972 May 01; 32(5):960-7. PubMed ID: 4502173 [No Abstract] [Full Text] [Related]
35. An evaluation of humoral antibody responses in patients with carcinoma of the cervix. Vos GH, Hammond MG, Vos D, Grobbelaar BG, Auslander HP, Marescotti G. J Obstet Gynaecol Br Commonw; 1972 Nov 01; 79(11):1040-6. PubMed ID: 4642378 [No Abstract] [Full Text] [Related]